Skip to content

Clinical trials

Phase 2 Sjogren's Syndrome trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sjogren's Syndrome Phase: Phase 2 Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20162
20192
20201
20213
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
Artiva Biotherapeutics, Inc.1
Assistance Publique - Hôpitaux de Paris1
GlaxoSmithKline1
Hoffmann-La Roche1
Institut de Recherches Internationales Servier1
Janssen Research & Development, LLC1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sjogren's Syndrome12
Autoimmune Diseases3
Dry Eye Syndromes2
Xerostomia2
Arthritis1
Arthritis, Rheumatoid1
Fatigue1
Joint Diseases1
Myositis1
Salivary Gland Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.